ALFA FinderBSE filing, NSE: PARMAX. Summary written from the filing by ALFA Finder's alert engine.
Parmax Pharma Ltd: key numbers
- Share price
- ₹135.00
- Market cap
- ₹50.51 Cr
- Revenue (annual)
- ₹12.11 Cr
- Net profit (annual)
- ₹-4.16 Cr
- P/E (TTM)
- -42.3×Sector 43.8×
- Promoter holding
- 64.66%+33.86% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Parmax Pharma Ltd
All →Parmax Pharma Management Change
Parmax Pharma's independent director Ami Shah resigned effective October 28, 2026. The exit follows a change in management and control of the company.
Parmax Pharma Other Announcement
Parmax Pharma Ltd filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as required by SEBI regulations.
Parmax Pharma Management Change
Parmax Pharma Ltd announced the resignation of Mr. Nikhil Uchat as an Independent Director of the Company, effective October 08, 2026.
Parmax Pharma Annual General Meeting
Parmax Pharma Ltd conducted its 32nd Annual General Meeting on September 29, 2026, covering routine business including financial statement adoption and board appointments.
Parmax Pharma Adverse Business Impact
Parmax Pharma reported a major fire incident at its Rajkot plant on September 28, 2026. Two employees were injured, and the company is currently assessing the financial damage.
Parmax Pharma Other Announcement
Parmax Pharma Ltd filed its quarterly shareholding pattern under Regulation 31. The disclosure reflects changes in promoter status following a previously concluded open offer.
Other board meeting date announcements
All →Associated Ceramics Board Meeting Date
Associated Ceramics has scheduled a board meeting on November 14, 2026 to consider unaudited standalone September 2026 half-yearly results. Advance notice; meeting not yet held.
Dudani Retail Board Meeting Date
Dudani Retail has given intimation of a board meeting on 14 November 2026 to consider unaudited half-year standalone results and related statements. The trading window stays closed until 48 hours after the results are declared.
Davin Sons Retail Board Meeting Date
Davin Sons Retail will hold a board meeting on 14 November 2026 to consider half-year results and a registered office shift. No amount is stated.
Shine Fashions (India) Board Meeting Date
Shine Fashions (India) has given prior intimation of a board meeting on 14 November 2026 to consider half-year results and a preferential fund raise. Trading window has been closed since 1 October 2026.
Gautam Exim Board Meeting Date
Gauam Exim will hold a board meeting on 14 November 2026 to consider unaudited half-year results. Trading window closes 30 November 2026, having opened 1 November 2026.
Sollfege Smart Electronics Board Meeting Date
Sollfege Smart Electronics will hold a board meeting on 14 November 2026 to consider unaudited half-year results. Trading window closes 8 to 15 November 2026.